BPC-157 has been studied across many tissue types, including tendon, ligament, muscle, bone, skin, and the gut lining, as summarized in a research review of BPC-157 and wound healing across multiple tissue types
Peak plasma concentrations (T) occur approximately 2472 hours after subcutaneous dosing, depending on the dose administered
However, many treatments offer only temporary improvements, and no single treatment is universally effective for all patients
BPC-157 Dosage Protocol: The Exact Schedule We Follow The standard BPC-157 dosage range for subcutaneous injection is 250 to 500 mcg once or twice daily, administered near the target injury site, over a cycle of four to six weeks
All products on this site are for research and development use only
[DOI] [PubMed] [Google Scholar] 255.Jiao D., Wong C.K., Tsang M.S., Chu I.M., Liu D., Zhu J., Chu M., Lam C.W